American Heart Journal
Volume 154, Issue 1 , Pages 79.e9-79.e15 , July 2007

Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects

  • Kazuo Eguchi, MD, PhD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tokyo, Japan
    • Center for Behavioral Cardiovascular Health, Division of General Medicine, Columbia University Medical Center, New York, NY
    • Corresponding Author InformationReprint requests: Kazuo Eguchi, Center for Behavioral Cardiovascular Health, Division of General Medicine, Columbia University Medical Center, 622 West 168th St, PH9-942 New York, NY 10032.
    • ,
  • Joji Ishikawa, MD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tokyo, Japan
    • ,
  • Satoshi Hoshide, MD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tokyo, Japan
    • ,
  • Shizukiyo Ishikawa, MD, PhD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tokyo, Japan
    • ,
  • Thomas G. Pickering, MD, DPhil

      Affiliations

    • Center for Behavioral Cardiovascular Health, Division of General Medicine, Columbia University Medical Center, New York, NY
    • ,
  • Joseph E. Schwartz, PhD

      Affiliations

    • Department of Psychiatry and Behavioral Science, State University of New York at Stony Brook, New York, NY
    • ,
  • Shunichi Homma, MD

      Affiliations

    • Department of Cardiology, Columbia University College of Physicians and Surgeons, New York, NY
    • ,
  • Kazuyuki Shimada, MD, PhD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tokyo, Japan
    • ,
  • Kazuomi Kario, MD, PhD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tokyo, Japan

Received 8 February 2007 ,Accepted 8 April 2007.

References 

  1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431
  2. Rodriguez BL, Curb JD, Burchfiel CM, et al. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Diabetes Care. 1996;19:587–590
  3. Guidelines Committee . 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–1053
  4. Japanese Society of Hypertension Subcommittee for the Management of Hypertension. Guidelines for the management of hypertension 2004 (JSH 2004). Hypertens Res. 2006;29(Suppl):S1–S105
  5. Sowers JR. Treatment of hypertension in patients with diabetes. Arch Intern Med. 2004;164:1850–1857
  6. U. K. Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713
  7. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550–1558
  8. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham heart study. J Am Coll Cardiol. 1995;25:879–884
  9. Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–352
  10. Muiesan ML, Salvetti M, Monteduro C, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004;43:731–738
  11. Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation. 2000;101:2271–2276
  12. Eguchi K, Kario K, Hoshide S, et al. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients. Am J Hypertens. 2005;18:23–29
  13. Sone H, Mizuno S, Ohashi Y, et al. Type 2 diabetes prevalence in Asian subjects. Response to McNeely and Boyko. Diabetes Care. 2004;27:1251–1252
  14. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1. Blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Circulation. 2005;111:697–716
  15. American Diabetes Association . Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:5S–10S
  16. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–1083
  17. Devereux R, Alonso D, Lutas E, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458
  18. Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222–1230
  19. Imai Y, Sasaki S, Minami N, et al. The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens. 1992;5:719–726
  20. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441–1446
  21. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol. 1996;78:197–202
  22. Phillips RA, Diamond JA. Left ventricular hypertrophy, congestive heart failure, and coronary flow reserve abnormalities in hypertension. In:  Oparil S,  Weber MA editor. Hypertension: a companion to Brenner and Rector's the kidney. Philadelphia (PA): Saunders; 2000;p. 244–277
  23. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25:543–567
  24. Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:595–602
  25. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA. 1974;229:1749–1754
  26. Factor SM, Borczuk A, Charron MJ, et al. Myocardial alterations in diabetes and hypertension. Diabetes Res Clin Pract. 1996;31(Suppl):S133–S142
  27. Palmieri V, Bella JN, Arnett DK, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001;103:102–107
  28. Fox ER, Taylor J, Taylor H, et al. Left ventricular geometric patterns in the Jackson cohort of the atherosclerotic risk in communities (ARIC) study: clinical correlates and influences on systolic and diastolic dysfunction. Am Heart J. 2007;153:238–244
  29. Palmieri V, Tracy RP, Roman MJ, et al. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care. 2003;26:2764–2769
  30. Chinali M, de Simone G, Roman MJ, et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol. 2006;47:2267–2373
  31. Araneta MR, Barnett-Connor E. Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obesity Res. 2005;13:1458–1465
  32. Bertoni AG, Goff DC, D'Agostino RB, et al. Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2006;29:588–594
  33. Mitchell BM, Gutin B, Kapuku G, et al. Left ventricular structure and function in obese adolescents: relations to cardiovascular fitness, percent body fat, and visceral adiposity, and effects of physical training. Pediatrics. 2002;109:e73-3
  34. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56–64
  35. Selvin E, Coresh J, Golden SH, et al. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28:1965–1973
  36. Nakano S, Ito T, Furuya K, et al. Ambulatory blood pressure level rather than dipper/nondipper status predicts vascular events in type 2 diabetic subjects. Hypertens Res. 2004;27:647–656

 This study was supported in part by grants-in-aid (1998–1999, 2001–2002, 2004–2005) from the Foundation for the Development of the Community, Tochigi, Japan, the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International, and NHLBI (R24 HL76857 and PO1 HL 47540).

PII: S0002-8703(07)00329-8

doi: 10.1016/j.ahj.2007.04.021

American Heart Journal
Volume 154, Issue 1 , Pages 79.e9-79.e15 , July 2007

Article Tools

* Image Usage & Resolution